VKTX
Price
$29.51
Change
+$0.90 (+3.15%)
Updated
May 2, 03:09 PM (EDT)
Capitalization
3.21B
82 days until earnings call
VYGR
Price
$3.63
Change
+$0.08 (+2.25%)
Updated
May 2, 03:10 PM (EDT)
Capitalization
196.36M
11 days until earnings call
Ad is loading...

VKTX vs VYGR

Header iconVKTX vs VYGR Comparison
Open Charts VKTX vs VYGRBanner chart's image
Viking Therapeutics
Price$29.51
Change+$0.90 (+3.15%)
Volume$10.26K
Capitalization3.21B
Voyager Therapeutics
Price$3.63
Change+$0.08 (+2.25%)
Volume$400
Capitalization196.36M
VKTX vs VYGR Comparison Chart
Loading...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VKTX vs. VYGR commentary
May 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VKTX is a StrongBuy and VYGR is a Buy.

Ad is loading...
COMPARISON
Comparison
May 02, 2025
Stock price -- (VKTX: $28.61 vs. VYGR: $3.55)
Brand notoriety: VKTX and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VKTX: 77% vs. VYGR: 71%
Market capitalization -- VKTX: $3.21B vs. VYGR: $196.36M
VKTX [@Biotechnology] is valued at $3.21B. VYGR’s [@Biotechnology] market capitalization is $196.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VKTX’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • VKTX’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, both VKTX and VYGR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VKTX’s TA Score shows that 5 TA indicator(s) are bullish while VYGR’s TA Score has 4 bullish TA indicator(s).

  • VKTX’s TA Score: 5 bullish, 4 bearish.
  • VYGR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than VYGR.

Price Growth

VKTX (@Biotechnology) experienced а +11.52% price change this week, while VYGR (@Biotechnology) price change was +0.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +8.32%, and the average quarterly price growth was -5.52%.

Reported Earning Dates

VKTX is expected to report earnings on Jul 23, 2025.

VYGR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($3.21B) has a higher market cap than VYGR($196M). VKTX YTD gains are higher at: -28.889 vs. VYGR (-37.390). VYGR has higher annual earnings (EBITDA): -78.56M vs. VKTX (-171.93M). VKTX has more cash in the bank: 852M vs. VYGR (267M). VKTX has less debt than VYGR: VKTX (1M) vs VYGR (43.7M). VYGR has higher revenues than VKTX: VYGR (80M) vs VKTX (0).
VKTXVYGRVKTX / VYGR
Capitalization3.21B196M1,640%
EBITDA-171.93M-78.56M219%
Gain YTD-28.889-37.39077%
P/E RatioN/A6.00-
Revenue080M-
Total Cash852M267M319%
Total Debt1M43.7M2%
FUNDAMENTALS RATINGS
VKTX vs VYGR: Fundamental Ratings
VKTX
VYGR
OUTLOOK RATING
1..100
2213
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
37
Fair valued
PROFIT vs RISK RATING
1..100
70100
SMR RATING
1..100
3491
PRICE GROWTH RATING
1..100
6365
P/E GROWTH RATING
1..100
1008
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (37) in the Biotechnology industry is in the same range as VKTX (47). This means that VYGR’s stock grew similarly to VKTX’s over the last 12 months.

VKTX's Profit vs Risk Rating (70) in the Biotechnology industry is in the same range as VYGR (100). This means that VKTX’s stock grew similarly to VYGR’s over the last 12 months.

VKTX's SMR Rating (34) in the Biotechnology industry is somewhat better than the same rating for VYGR (91). This means that VKTX’s stock grew somewhat faster than VYGR’s over the last 12 months.

VKTX's Price Growth Rating (63) in the Biotechnology industry is in the same range as VYGR (65). This means that VKTX’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for VKTX (100). This means that VYGR’s stock grew significantly faster than VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VKTXVYGR
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNPFX62.470.21
+0.34%
American Funds New Perspective R5
BLUEX39.88N/A
N/A
AMG Veritas Global Real Return I
BIVRX16.61N/A
N/A
Invenomic Investor
INDSX17.73N/A
N/A
ALPS/Kotak India ESG II
MGHRX55.33N/A
N/A
Morgan Stanley Inst Growth IR

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with MREO. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then MREO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
-0.88%
MREO - VKTX
44%
Loosely correlated
+0.39%
KRYS - VKTX
44%
Loosely correlated
-2.47%
ALT - VKTX
43%
Loosely correlated
-1.52%
CRNX - VKTX
43%
Loosely correlated
+0.39%
ROIV - VKTX
43%
Loosely correlated
-0.34%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-0.28%
RGNX - VYGR
50%
Loosely correlated
+2.29%
TRDA - VYGR
48%
Loosely correlated
-0.88%
IMNM - VYGR
47%
Loosely correlated
+0.80%
XENE - VYGR
46%
Loosely correlated
-0.29%
RCKT - VYGR
46%
Loosely correlated
+3.01%
More